0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hodgkin lymphoma (HL) survivors are at increased risk of thyroid cancer (TC). We sought to determine whether increased risks of high-risk pathology or mortality are seen with thyroid cancer after HL (HL-TC) compared with first primary thyroid cancer (TC-1). From the Surveillance, Epidemiology and End Results (SEER) registry, we compared patient and tumor characteristics as well as survival outcomes between HL-TC and TC-1 and fit a multivariable Cox model to assess for a possible association between HL history and overall survival after TC. Among 139,297 TC-1 and 174 HL-TC patients, history of HL was not associated with anaplastic or sarcoma TC. Multivariable analyzes showed that history of HL was not associated with a difference in risk of death after TC (hazard ratio: 0.96, 95% confidence interval: (0.81, 1.13), p = .61). Despite a significantly increased risk of TC among HL survivors, prior HL is not associated with more aggressive pathologic subtypes or worse prognosis.

          Related collections

          Author and article information

          Journal
          Leuk. Lymphoma
          Leukemia & lymphoma
          Informa UK Limited
          1029-2403
          1026-8022
          May 2018
          : 59
          : 5
          Affiliations
          [1 ] a University of Rochester School of Medicine , Rochester , NY , USA.
          [2 ] b University of Rochester Medical Center , Division of Medical Oncology , Rochester , NY , USA.
          [3 ] c Department of Radiation Oncology , Massachusetts General Hospital , Boston , MA , USA.
          [4 ] d Department of Radiation Oncology , University of Rochester Medical Center , Rochester , NY , USA.
          Article
          10.1080/10428194.2017.1369063
          28862484
          d946ba72-040a-4ccd-9235-64852c513812
          History

          thyroid cancer,Hodgkin lymphoma,Second malignancy,cancer survivorship

          Comments

          Comment on this article